loadpatents
name:-0.053086042404175
name:-0.026927947998047
name:-0.016818046569824
BARLAAM; Bernard Christophe Patent Filings

BARLAAM; Bernard Christophe

Patent Applications and Registrations

Patent applications and USPTO patent grants for BARLAAM; Bernard Christophe.The latest application filed is for "estrogen receptor degrading protacs".

Company Profile
18.31.52
  • BARLAAM; Bernard Christophe - Cambridge GB
  • BARLAAM; Bernard Christophe - Macclesfield GB
  • Barlaam; Bernard Christophe - Cheshire GB
  • Barlaam; Bernard Christophe - Reims N/A FR
  • Barlaam; Bernard Christophe - Reims, Cedex N/A FR
  • BARLAAM; Bernard Christophe - Cedex FR
  • Barlaam; Bernard Christophe - Wilmington DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Estrogen Receptor Degrading Protacs
App 20220169643 - YANG; Bin ;   et al.
2022-06-02
Deuterated Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20210347775 - PIKE; Kurt Gordon ;   et al.
2021-11-11
Chemical Compounds
App 20210284636 - BARLAAM; Bernard Christophe ;   et al.
2021-09-16
Selective estrogen receptor down-regulators
Grant 11,046,689 - Nissink , et al. June 29, 2
2021-06-29
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20210147416 - Barlaam; Bernard Christophe ;   et al.
2021-05-20
Chemical compounds
Grant 10,961,241 - Barlaam , et al. March 30, 2
2021-03-30
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
Grant 10,882,858 - Barlaam , et al. January 5, 2
2021-01-05
Selective Estrogen Receptor Down-Regulators
App 20200239468 - Nissink; Johannes Wilhelmus Maria ;   et al.
2020-07-30
Chemical Compounds
App 20200239467 - BARLAAM; Bernard Christophe ;   et al.
2020-07-30
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20200102302 - Barlaam; Bernard Christophe ;   et al.
2020-04-02
Deuterated Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20200087300 - PIKE; Kurt Gordon ;   et al.
2020-03-19
Selective estrogen receptor down-regulators
Grant 10,590,132 - Nissink , et al.
2020-03-17
Chemical compounds
Grant 10,590,130 - Barlaam , et al.
2020-03-17
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
Grant 10,457,679 - Barlaam , et al. Oc
2019-10-29
Chemical Compounds
App 20190233413 - Nissink; Johannes Wilhelmus Maria ;   et al.
2019-08-01
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20190185468 - BARLAAM; Bernard Christophe ;   et al.
2019-06-20
N-Oxide Compound and Its Use in Treating Cancer
App 20190119270 - BARLAAM; Bernard Christophe ;   et al.
2019-04-25
Chemical Compounds
App 20190100520 - BARLAAM; Bernard Christophe ;   et al.
2019-04-04
Cinnolin-4-amine Compounds And Their Use In Treating Cancer
App 20190099421 - PIKE; Kurt Gordon ;   et al.
2019-04-04
Chemical compounds
Grant 10,221,173 - Nissink , et al.
2019-03-05
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
Grant 10,189,834 - Barlaam , et al. Ja
2019-01-29
Chemical compounds
Grant 10,149,839 - Scott , et al. Dec
2018-12-11
Chemical compounds
Grant 10,131,663 - Barlaam , et al. November 20, 2
2018-11-20
Chemical compounds
Grant 10,125,135 - Yang , et al. November 13, 2
2018-11-13
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20180318287 - PIKE; Kurt Gordon ;   et al.
2018-11-08
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20180280377 - PIKE; Kurt Gordon ;   et al.
2018-10-04
Chemical Compounds
App 20180282325 - Nissink; Johannes Wilhelmus Maria ;   et al.
2018-10-04
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20180141943 - Barlaam; Bernard Christophe ;   et al.
2018-05-24
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20180134699 - BARLAAM; Bernard Christophe ;   et al.
2018-05-17
Chemical Compounds
App 20180111931 - BARLAAM; Bernard Christophe ;   et al.
2018-04-26
Chemical Compounds
App 20180021316 - Scott; James Stewart ;   et al.
2018-01-25
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
Grant 9,856,255 - Barlaam , et al. January 2, 2
2018-01-02
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
Grant 9,822,111 - Barlaam , et al. November 21, 2
2017-11-21
Chemical Compounds
App 20170305909 - YANG; Bin ;   et al.
2017-10-26
Chromenone derivatives
Grant 9,718,800 - Barlaam , et al. August 1, 2
2017-08-01
Chemical compounds
Grant 9,657,008 - Barlaam , et al. May 23, 2
2017-05-23
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20170081325 - Barlaam; Bernard Christophe ;   et al.
2017-03-23
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20160368920 - BARLAAM; Bernard Christophe ;   et al.
2016-12-22
Chromenone Derivatives
App 20160272607 - BARLAAM; Bernard Christophe ;   et al.
2016-09-22
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating Cancer
Grant 9,428,503 - Barlaam , et al. August 30, 2
2016-08-30
Chemical Compounds
App 20160137634 - Barlaam; Bernard Christophe ;   et al.
2016-05-19
Chromenone Derivatives
App 20160060240 - BARLAAM; Bernard Christophe ;   et al.
2016-03-03
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20150336952 - BARLAAM; Bernard Christophe ;   et al.
2015-11-26
Chemical compounds
Grant 9,156,831 - Barlaam , et al. October 13, 2
2015-10-13
Chromenone derivatives
Grant 9,029,374 - Barlaam , et al. May 12, 2
2015-05-12
Chemical Compounds
App 20140206700 - BARLAAM; Bernard Christophe ;   et al.
2014-07-24
Chromenone Derivatives
App 20140194419 - BARLAAM; Bernard Christophe ;   et al.
2014-07-10
Chromenone derivatives
Grant 8,673,906 - Barlaam , et al. March 18, 2
2014-03-18
Chromenone Derivatives
App 20140038937 - BARLAAM; Bernard Christophe ;   et al.
2014-02-06
Pyridine compounds
Grant 8,569,298 - Barlaam , et al. October 29, 2
2013-10-29
Chromenone derivatives
Grant 8,530,470 - Barlaam , et al. September 10, 2
2013-09-10
Chromenone Derivatives
App 20130158026 - BARLAAM; Bernard Christophe ;   et al.
2013-06-20
Quinazoline Derivatives
App 20120329795 - Hennequin; Laurent Francois Andre ;   et al.
2012-12-27
Chromenone Derivatives
App 20120264731 - BARLAAM; Bernard Christophe ;   et al.
2012-10-18
Quinazoline Derivatives as Antiproliferative Agents
App 20110237610 - Barlaam; Bernard Christophe ;   et al.
2011-09-29
Pyridine and pyrazine derivatives -083
Grant 8,017,611 - Barlaam , et al. September 13, 2
2011-09-13
Pyridine Compounds
App 20110166139 - Barlaam; Bernard Christophe ;   et al.
2011-07-07
Pyrazolo[3,4-d]pyrimidine compounds as antitumor agents
Grant 7,947,676 - Barlaam , et al. May 24, 2
2011-05-24
Chromenone Derivatives
App 20110098271 - BARLAAM; Bernard Christophe ;   et al.
2011-04-28
Pyrimidine Derivatives
App 20110046108 - Kettle; Jason Grant ;   et al.
2011-02-24
Quinazoline derivatives as antiproliferative agents
Grant 7,838,530 - Barlaam , et al. November 23, 2
2010-11-23
4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB receptor tyrosine kinase inhibitors for the treatment of cancer
Grant 7,820,683 - Bradbury , et al. October 26, 2
2010-10-26
4-anilino-substituted Quinazoline Derivatives As Tyrosine Kinase Inhibitors
App 20100222344 - Barlaam; Bernard Christophe
2010-09-02
Pyrimidine derivatives for inhibiting Eph receptors
Grant 7,718,653 - Barlaam , et al. May 18, 2
2010-05-18
Pyridine And Pyrazine Derivatives - 083
App 20090118305 - Barlaam; Bernard Christophe ;   et al.
2009-05-07
Novel Pyrimidine Derivatives 965
App 20090054428 - Barlaam; Bernard Christophe ;   et al.
2009-02-26
4-(1h-indazol-5-yl-amino)-quinazoline Compounds As Erbb Receptor Tyrosine Kinase Inhibitors For The Treatment Of Cancer
App 20090048251 - Bradbury; Robert Hugh ;   et al.
2009-02-19
Novel Pyrimidine Derivatives - 816
App 20090036440 - BARLAAM; Bernard Christophe ;   et al.
2009-02-05
Quinazoline Derivatives Used As Inhibitors Of Erbb Tyrosine Kinase
App 20090029968 - Barlaam; Bernard Christophe ;   et al.
2009-01-29
Pyrimidine Derivatives 934
App 20090023719 - Barlaam; Bernard Christophe ;   et al.
2009-01-22
Novel Pyrimidine Derivatives 698
App 20080242663 - Ashton; Susan Elizabeth ;   et al.
2008-10-02
Pyrazolopyrimidine Compounds as Antitumor Agents
App 20080108613 - Barlaam; Bernard Christophe ;   et al.
2008-05-08
Quinazoline Derivatives
App 20080096881 - Hennequin; Laurent Francois Andre ;   et al.
2008-04-24
Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
Grant 7,342,020 - Barlaam , et al. March 11, 2
2008-03-11
Quinazoline Derivatives as Erbb Receptor Tyrosine kinases
App 20070232607 - Bradbury; Robert Hugh ;   et al.
2007-10-04
Quinazoline derivatives
App 20070037837 - Hennequin; Laurent Francois Andre ;   et al.
2007-02-15
Quinazoline derivatives as tyrosine kinase inhibitors
App 20070032508 - Bradbury; Robert Hugh ;   et al.
2007-02-08
Quinazoline derivatives as antiproliferative agents
App 20060287295 - Barlaam; Bernard Christophe ;   et al.
2006-12-21
Metalloproteinase inhibitor compounds
Grant 7,122,551 - Barlaam , et al. October 17, 2
2006-10-17
Arylpiperazines and their use as metallaproteinase inhibiting agents (mmp)
App 20030100548 - Barlaam, Bernard Christophe ;   et al.
2003-05-29
Estrogen receptor-.beta. ligands
Grant 6,518,301 - Barlaam , et al. February 11, 2
2003-02-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed